研究者業績

稲毛 一秀

イナゲ  (Kazuhide Inage)

基本情報

所属
千葉大学 大学院医学研究院 整形外科学 助教

研究者番号
80793629
J-GLOBAL ID
202101008138224648
researchmap会員ID
R000028120

主要な研究キーワード

 4

学歴

 1

論文

 1125
  • Hiroto Chikubu, Kazuhide Inage, Sumihisa Orita, Yasuhiro Shiga, Masahiro Inoue, Keisuke Shimizu, Miyako Suzuki-Narita, Ikuko Tajiri, Michiaki Mukai, Natsuko Nozaki-Taguchi, Seiji Ohtori
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2024年9月22日  
    Co-administration of mirogabalin besylate and nonsteroidal anti-inflammatory drugs is effective for neuropathic pain; however, mechanism of its action remains unknown. We aimed to evaluate the mechanism of this synergistic effect of the concomitant administration for neuropathic pain using chronic constriction injury model rats. Fifty male Wister rats of 7-week-old were used. Right sciatic nerve ligation was performed in 40 rats and they were sub-divided into four groups: vehicle, mirogabalin, diclofenac sodium and co-administration of them. Ten rats underwent sham surgery. Fluorogold was attached to sciatic nerve during surgery. Von Frey filament and weight bearing tests were performed on postoperative Day 6 as behavioral assessments and drug was administrated intraperitoneally. Half rats in each group underwent behavioral assessment and perfusion fixation using 4% paraformaldehyde on postoperative Day 7 and remaining on postoperative Day 14. Subsequently, dorsal root ganglion at L4 to L6 was collected and examined immunohistochemistry for calcitonin gene-related peptide, and their immunoreactivity in fluorogold-labeled neurons was measured. Spinal cord at lumbar swelling was resected, immunostained for ionized-calcium-binding adapter molecule-1 and glial fibrillary acidic protein, and immunoreactive neurons in dorsal horn of spinal cords were calculated as the occupancy of them. Mirogabalin suppresses the neuropeptide-release from presynaptic afferent neuron directly and it resulted in suppressing glia cells activation. Diclofenac sodium inhibits cyclooxygenase-2 and prostaglandin production, related to allodynia. These effects of mirogabalin and diclofenac sodium, respectively, inhibited glia cells strongly, which is presumed to be one of the mechanisms for the effectiveness of their co-administration for neuropathic pain.
  • Masahiro Inoue, Shiro Sugiura, Taiki Takeda, Takato Hoshino, Keisuke Shimizu, Kazuhide Inage, Yasuhiro Shiga, Kohei Okuyama, Seiji Ohtori, Sumihisa Orita
    Cureus 2024年8月26日  
  • Yuya Kawarai, Junichi Nakamura, Shigeo Hagiwara, Miyako Suzuki-Narita, Kazuhide Inage, Seiji Ohtori
    Journal of orthopaedic surgery and research 19(1) 357-357 2024年6月16日  
    BACKGROUND: This study aimed to validate alterations in the gene expression of DNA methylation-related enzymes and global methylation in the peripheral blood mononuclear cell (PBMC) and synovial tissues of animal hip osteoarthritis (OA) models. METHODS: Animals were assigned to the control (no treatment), sham (25 µL of sterile saline), and OA (25 µL of sterile saline and 2 mg of monoiodoacetate) groups. Microcomputed tomography scan, histopathological assessment and pain threshold measurement were performed after induction. The mRNA expression of the DNA methylation machinery genes and global DNA methylation in the PBMC and hip synovial tissue were evaluated. RESULTS: The OA group presented with hip joint OA histopathologically and radiologically and decreased pain threshold. The mRNA expression of DNA methyltransferase (Dnmt 3a), ten-eleven translocation (Tet) 1 and Tet 3 in the synovial tissue of the OA group was significantly upregulated. Global DNA methylation in the synovial tissue of the OA group was significantly higher than that of the control and sham groups. CONCLUSIONS: The intra-articular administration of monoiodoacetate induced hip joint OA and decreased pain threshold. The DNA methylation machinery in the synovial tissues of hip OA was altered.
  • Soichiro Tokeshi, Yawara Eguchi, Takayuki Sakai, Masami Yoneyama, Atsuya Watanabe, Yasuchika Aoki, Masashi Sato, Sumihisa Orita, Miyako Suzuki, Kazuhide Inage, Yasuhiro Shiga, Masahiro Inoue, Noriyasu Toshi, Kohei Okuyama, Shuhei Ohyama, Noritaka Suzuki, Satoshi Maki, Junichi Nakamura, Shigeo Hagiwara, Yuya Kawarai, Tsutomu Akazawa, Hiroshi Takahashi, Seiji Ohtori
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 125 97-103 2024年5月17日  
    PURPOSE: MIXTURE is a simultaneous morphological and quantitative imaging sequence developed by Philips that provides high-resolution T2 maps from the imaged series. We aimed to compare the T2 maps of MIXTURE and SHINKEI-Quant (S-Q) in the cervical spine and to examine their usefulness in the functional diagnosis of cervical radiculopathy. METHODS: Seven healthy male volunteers (mean age: 31 ± 8.0 years) and one patient with cervical disc herniation (44 years old, male) underwent cervical spine magnetic resonance imaging (MRI), and T2-mapping of each was performed simultaneously using MIXTURE and S-Q in consecutive sequences in one imaging session. The standard deviation (SD) of the T2 relaxation times and T2 relaxation times of the bilateral C6 and C7 dorsal root ganglia (DRG) and C5/6 level cervical cord on the same slice in the 3D T2-map of the cervical spine coronal section were measured and compared between MIXTURE and S-Q. RESULTS: T2 relaxation times were significantly shorter in MIXTURE than in S-Q for all C6, C7 DRG, and C5/6 spinal cord measurements. The SD values of the T2 relaxation times were significantly lower for MIXTURE in the C5/6 spinal cord and C7 DRG. In cervical disc herniation, MRI showed multiple intervertebral compression lesions with spinal canal stenosis at C5/6 and disc herniation at C6/7. CONCLUSION: MIXTURE is useful for preoperative functional diagnosis. T2-mapping using MIXTURE can quantify cervical nerve roots more accurately than the S-Q method and is expected to be clinically applicable to cervical radiculopathy.
  • Yawara Eguchi, Noritaka Suzuki, Sumihisa Orita, Kazuhide Inage, Miyako Narita, Yasuhiro Shiga, Masahiro Inoue, Noriyasu Toshi, Soichiro Tokeshi, Kohei Okuyama, Shuhei Ohyama, Satoshi Maki, Yasuchika Aoki, Junichi Nakamura, Shigeo Hagiwara, Yuya Kawarai, Tsutomu Akazawa, Masao Koda, Hiroshi Takahashi, Seiji Ohtori
    World neurosurgery 185 e1144-e1152 2024年5月  
    OBJECTIVE: The goal of this study was to evaluate, using computed tomography (CT) and magnetic resonance imaging (MRI), patients who underwent oblique lateral interbody fusion (OLIF) using either expandable or static interbody spacers. METHODS: Thirty-five patients with degenerative disc disease were surgically treated with one-level OLIF and were followed up for more than 6 months. The Static group consisted of 22 patients, and 13 patients were in the Expandable group. Intraoperative findings included operative time (min), blood loss (ml), and cage size. Low back pain, leg pain, and leg numbness were measured using the Japanese Orthopedic Association score, visual analogue score, and the Roland-Morris Disability Questionnaire. Radiologic evaluation using computed tomography (CT) and magnetic resonance imaging (MRI) allowed measurement of cage subsidence, cross-sectional area (CSA) of the dural sac, disc height, segmental lordosis, foraminal height, and foraminal CSA preoperatively and 6 months postoperatively. RESULTS: The Expandable group had significantly larger cage height and lordosis than the Static group (P < 0.05). The Expandable group also had greater dural sac area expansion and enlargement of the intervertebral foramen, as well as better correction of vertebral body slip (P < 0.05). Cage subsidence was significantly lower in the Expandable group (P < 0.05). JOA and VAS scores for leg numbness were significantly better in the Expandable group (P < 0.05). CONCLUSIONS: Compared with static spacers, expandable spacers significantly enlarged the dural sac area, corrected vertebral body slippage, expanded the intervertebral foramen, and achieved good indirect decompression while reducing cage subsidence, resulting in improvement in clinical symptoms.

MISC

 65

共同研究・競争的資金等の研究課題

 7

産業財産権

 1